EyePoint Pharmaceuticals (EYPT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

EyePoint Pharmaceuticals (EYPT) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

EyePoint Pharmaceuticals

· EYPT

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

294.846 M

-4.39%

General

Market Cap: $294.85M
Enterprise Value: $186.07M
Shares Outstanding: 83,840,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 41.77%
Operating Margin: -11365.22%
Net Profit Margin: -10994.73%
FCF Margin: -9726.75%
ROA: -134.38%
ROE: -135.81%
ROIC: -167.81%
Current Ratio: 4.50
Debt-to-Equity: 0.13
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.02
P/S: 98.30
P/FCF: —
P/B: 1.65
EV/EBITDA: -0.63

Growth

Rev 1Y: -27.50%
Rev 1Y Fwd Est: -94.52%
Rev 3Y (CAGR): -8.83%
Rev 5Y (CAGR): -1.85%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $2.79M
Gross Margin: 41.77%
Operating Expenses: $318.14M
Operating Income: -$316.98M
Net Profit: -$306.64M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $110.46M
Working Capital: $146.87M
Total Assets: $228.19M
Net Debt: -$88.09M
Total Liabilities: $61.78M
Total Equity: $166.41M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$267.3M
Cash Flow from Investing: $114.88M
Cash Flow from Financing: $191.74M
Free Cash Flow: -$271.28M
Capital Expenditures: $3.98M